Frontlight ResearchEarly access
Trial site
Synexus Clinical Research US, Inc.
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Mild cognitive impairment1 trial
- Osteoarthritis1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Eisai Inc.1 trial
Running trials
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Osteoarthritis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026